Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Mrs Amy Burns
+44 (0)191 404 1000 ext 2237
amy.burns6@nhs.net


More information about this study, what is involved and how to take part can be found on the study website.

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Colorectal cancer cohort study (COLO-COHORT)

Colorectal cancer cohort study (COLO-COHORT)

Recruiting

Open to: All Genders

Age: Adult

Medical Conditions

Colorectal neoplasia, colorectal cancer


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Not provided at time of registration

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Aug 2019 14 Jan 2026

Observational

Intervention Type : Other
Intervention Description : Group A (cross-sectional arm, 10,000 patients)In 6,000 patients from this group, patients will be asked to submit a Faecal Immunochemical Test (FIT) sample and be asked to have blood tests taken including blood for DNA extraction. In the remaining patients, we will record recent blood results of interest. For all patients, we will obtain information on their past medical history, alcohol history, smoking history, family history, anthropometric measurements including waist circumference, and information from their colonoscopy and histology of polyps removed or biopsies taken.

COLO-SPEED, Group B:Patients will be asked to consent to future contact for collection of additional information, contact for future research studies, use of samples or information from this study to be used in future research studies, for longitudinal follow up through medical notes or national databases, and use of information from previous lower gastrointestinal endoscopy and histology as well as laboratory results in future research studies.

Follow up for patients who consent for long term follow up will be 10 years post consent.




You can take part if:



You may not be able to take part if:


Group A:1. Unable to give informed consent2. Known polyposis syndrome3. Previous total colectomy4. Known colonic stricture which would limit complete colonoscopy5. Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent 6. Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance7. Patients currently recruited into an interventional CTIMP for CRC prevention

COLO-SPEED (Group B):1. DOes not meet inclusion criteria


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • South Tyneside District Hospital
    Harton Lane
    South Shields
    NE34 0PL

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.

Mrs Amy Burns
+44 (0)191 404 1000 ext 2237
amy.burns6@nhs.net



More information about this study, what is involved and how to take part can be found on the study website.


The study is sponsored by South Tyneside and Sunderland NHS Foundation Trust and funded by Guts UK Charity.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN17473023
Last updated 25 April 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.